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Results: The tumour volume, assessed at the planning CTscan, had a 
median of 26.9ml range: 0,6-527,8ml. At the 1.-30.fr the tumour 
change between the visual and algorithm assessment obtained a 82-
97% agreement (k=0,65-0,94). At the 30.fr. the tumour change 
between the visual and doctor assessment had a 89% agreement 
(k=0,70). Tumour shrinkage was observed in 12pts.  
Furthermore, at the 30.fr, there was no statistically significant 
difference between the tumour-change assessment of the 
doctor(mean:19,2ml 95%CI:10, 1-36,2ml) and the algorithm (mean: 
19,6ml 95%CI:10,5-36,5ml), p=0,85. At the 30.fr there was an 89% 
(24pts) observed agreement between the three methods. Overall only 
1pt had tumour growth >5ml. 
Conclusions: The inter-tester reproducibility of tumour-change 
between the three methods is good. The visual, doctor and algorithm 
assessments had an agreement of 89%. There was no statistically 
significant difference between the tumour-change assessment of the 
doctor and the algorithm. Visual inspection may be used to determine 
tumour shrinkage during the radiotherapy course.  
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Purpose/Objective: To develop and implement a non-invasive head 
frame for intracranial stereotactic radiotherapy (SRT). While 
maintaining and improving treatment accuracy it was important to 
make the new SRT/SRS frame more efficient, more comfortable for 
the patients and easier to use for the therapists. We analyzed set up 
accuracy and intra-fractional motion of the new frame (Civco Medical 
systems) in comparison to the currently used system (BrainLab).  
Materials and Methods: Twenty patients (140 fractions) were treated 
with the CIVCO SRS frame, 19 Patients (152 fractions) were treated 
with the Brainlab system. The CIVCO frame contains no metal parts 
making it MRI compatible. Additionally, it allows for better gantry 
clearance compared to the Brainlab system. Patients were treated 
either using a VMAT or IMRT technique. Image guidance was 
performed using CBCT. All positioning discrepancies were documented 
including pitch and roll. If pitch or roll was greater than 1.5° patient 
setup was repeated. Translational and rotational errors were 
corrected daily. A post treatment CBCT was acquired to analyse intra-
fractional patient stability.  
Results: The setup based on lasers and isocenter marks on the mask is 
equally accurate in both systems with an accuracy of approximately 2 
mm. The uncertainty in longitudinal direction is slightly reduced with 
the CIVCO system compared to the Brainlab system. Analysis of the 
CBCTs showed an increased roll for the patients being fixed with the 
CIVCO system (CIVCO: -0.143° ± 1.403°, Brainlab:-0.020° ± 0.028°). 
This lead to an increased frequency of patient reset-ups due to a pitch 
value outside tolerance. The intra-fractional motion was small and 
comparable between both systems in lateral and longitudinal 
direction, but was significantly larger for the Brainlab system in 
vertical direction (CIVCO: -0.02 (±0.23) mm, Brainlab: VRT: -0.21 
(±0.41) mm, p<10-3). The observed systematic shift of the Brainlab 
mask in vertical direction is likely related to the sagging of the 
patient.  
Conclusions: Intra-fractional motion with the CIVCO frame proved to 
be slightly less than with the Brainlab system while the pitch and roll 
deviations in initial setup proved to be marginally larger. Pitch and 
roll can be corrected easily with a 6 DOF table or by repositioning the 
patient. Future studies will include frame efficacy, handling and 
patient comfort. 
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Purpose/Objective: The aim of this study is to compare four different 
5-point fixation commercial thermoplastic masks (A, B, C and D) in 
combination with two different kinds of head supports (a and b) and 
then verify witch combination has less margin of error to get the best 
immobilisation system. 
Materials and Methods: 34 patients with head and neck cancer were 
treated by using Intensity Modulated Radiotherapy (IMRT) and Rapid 
Arc (RA) therapy on a Varian® linear accelerator with an On Board 
Imager (OBI) system. All patients had Image Guided Radiotherapy 
(IGRT) using kilovoltage (KV) and megavoltage (MV) images at 
fractions 1-2-3 and then weekly once the systematic errors had been 
corrected and the random errors were within departmental 
tolerances. In total 505 images were evaluated. 
The KV-MV images were compared with Digital Reconstructed 
Radiographs (DRR) to define the patient translation in the vertical 
(anterior-posterior), longitudinal (cranial-caudal) and lateral (right-
left) axis. Using these measurements, we calculated for each group 
the systematic (∑syst) and random error (σrandom). 
To determine if there was a statistical significant difference between 
the different masks within one head support group, we used the 
Kruskal-Wallis ANOVA test. For the difference between the same type 
of mask but with different head supports, we used the Mann-Whitney 
U test. 
Results: Evaluation of the 5-point thermoplastic fixation mask and 
head support (values are in centimeters). 
 
 
Mask A was stopped after four patients, because there were 
difficulties modulating and removing the mask from the patient's 
head. For this reason no patients were include with this mask and 
head support b. 
Conclusions: The study showed us that there is no statistical 
significant difference in systematic and random error between mask 
A,B,C and D. There is also no statistical significant difference between 
the two head supports, but all systematic and random errors for head 
support b are equal or lower than for head support a. 
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Purpose/Objective: To assess the geometric accuracy, image quality 
and precision of image registration of a new CT/MR-SIM localisation 
protocol, for patients immobilised with the MR-compatible Type-S 
frame undergoing head and neck radiotherapy. 
Materials and Methods: At our institution, Radiation Therapists 
routinely perform treatment planning CT and MRI scans, as well as CT-
MR image registration. This retrospective quality assurance study is an 
RT-led review of the CT-MRI SIM localisation protocol for patients 
undergoing head and neck radiotherapy. T1/T2 FSE MR-SIM images 
from the base of brain to below the clavicles, fused with a planning 
CT were reviewed for twenty patients immobilized using the MR 
compatible Type-S system and imaged in the treatment position, using 
a novel open architecture coil array. For the effective FOV and the 
pulse sequences utilized, phantom measurements were performed to 
quantify system related residual geometric distortions after 
application of a 3D commercial gradient distortion correction 
algorithm. Image quality analysis was performed by assessing coverage 
and measuring SNR and CNR in ten anatomical structures routinely 
contoured for RT planning. This data was benchmarked against an 
initial commissioning study for the coil. Accuracy of MR-CT image 
fusion was assessed for different levels of the head and neck, by 
performing multiple local registrations (superiorly, mid and inferiorly) 
and assessing concordance of pre-defined anatomical points. 
Results: For all cases reviewed, the localisation protocol routinely 
provided high resolution MR-SIM images with coverage from the base 
of brain to below the clavicles, in the treatment position. From 
phantom studies, residual distortions were found to be ≤1.0mm within 
a 10 cm radius and < 1.5 mm within a 15 cm radius of the scan centre. 
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Image registration accuracy was<2mm for all anatomic head and neck 
landmark displacements in the x, y and z direction relative to CT.  
Image quality was found to be comparable to the commissioning 
benchmark. SNR data for T1 FSE and T2 FSE were not statically 
significantly different (p= 0.53, 0.10) from benchmark dataset. 
However, the benchmark configuration appears to provide more 
optimized signal across all anatomical structures. For superficial 
structures closer to the surface, e.g. parotid, the RT coil provides 
very high signal due to closer proximity of the coil (T1 FSE mean RT 
126.1 v diagnostic 99.8). For deeper structures the converse is true, 
e.g. brainstem (mean SNR RT 33.7 v diagnostic 58.2).  
Conclusions: Benchmarking of the system and clinical process has 
allowed for the development of an MR-SIM quality assurance program 
for this anatomical site, with well defined imaging and image 
registration metrics.  
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Purpose/Objective: The dose-volume effect of radiation on breast 
tissue is poorly understood with few attempts at modeling the Normal 
Tissue Complication Probability (NTCP). This study estimates the NTCP 
parameter values for breast fibrosis after external beam breast 
radiation therapy (RT).  
Materials and Methods: Individual patient data of 5282 patients from 
the multi-centre EORTC 22881-10882 'boost versus no boost' trial and 
574 patients from the Cambridge breast IMRT trial were pooled and 
analysed. All patients received whole breast irradiation (WBI) (40Gy in 
15 fractions over 3 weeks or 50Gy in 25 fractions over 5 weeks) 
followed by tumour bed (TB) boost in some cases. A two compartment 
dose volume histogram (DVH) model was used with TB volume 
receiving WBI plus boost dose as the first compartment and whole 
breast volume outside the TB volume receiving WBI dose alone as 
second compartment. Two NTCP models were considered: (a) Lyman 
Kutcher Burman (LKB) model and (b) Niemierko model. The model 
parameters (BEUD50, m or γ50 and n)) for moderate-severe breast 
fibrosis were estimated using the Maximum Likelihood Estimation 
(MLE) method. To account for hypofractionation, a biologically 
equivalent dose (BED3) was generated using α/β of 3Gy. The 
parameter 95% confidence intervals (CI) were generated using the 
Profile Likelihood Estimation method. Summary data from the START 
pilot trial (n=1410) were used to asses the goodness of fit of the 
predicted NTCP model using the Pearson chi-square test. 
Results: One hundred and fifty four patients (26.8%) in the Cambridge 
trial and one thousand and ninety six patients (20.7%) in the EORTC 
trial developed moderate-severe breast fibrosis. Using the MLE 
method, the best estimated NTCP parameters were BEUD3(50) 
=136.4Gy, γ50=0.9 and n=0.011 for the Niemierko model and 
BEUD3(50) =132Gy, m=0.35 and n=0.012 for the LKB model. A small 
value of volume parameter 'n' suggests that for moderate-severe 
fibrosis, breast tissue is a serial organ. The observed rates of 
moderate-severe fibrosis in the START pilot trial were in good 
agreement to the predicted rates from the above models (χ2=0.05; 
p=0.95 with five degrees of freedom) Figure 1. 
 
 
Conclusions: This large multi-centre pooled study indicates that the 
effect of volume parameter is small and the maximum radiotherapy 
dose is the most important parameter to influence late breast fibrosis. 
Clinical validation of these results from future prospective studies is 
suggested. 
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Purpose/Objective: Breast cancer is the most commonly diagnosed 
female cancer, and with good survival rates, it is imperative that any 
potential long term side effects from this effective treatment are 
reduced. Techniques specific to patient cohorts with differing local 
recurrence risk factors are likely to be the new standard of care in 
breast radiotherapy in 5 to 10 years. These techniques include 
simultaneous integrated boost (SIB) and conformal non co-planar 
beam arrangements for accelerated partial breast irradiation (APBI). 
These beam arrangements distribute the dose throughout the body in 
a different pattern to the standard treatment. This work reports a 
comparison of the risk for these modern radiotherapy techniques, 
including the use of image guidance.  
Materials and Methods: Five treatment plans were created on a 
patient CT scan: standard whole breast treatment (WBRT), conformal 
non co-planar five field plan for an APBI treatment, two volume/two 
dose level SIB plan with 5 fields, three volume/three dose level SIB 
plan with 7 fields (forward planned), three volume/three dose level 
SIB plan with 7 fields (inverse planned). The plans were transferred to 
a whole body phantom. Regions in the phantom which represented 
radiosensitive organs were delineated and thermoluminescent 
dosimeters (TLD) used to measure the dose. Dose from a breast 
imaging kilovoltage cone beam CT protocol was measured with TLD in 
the same regions. These dose data were used as input into the 
Biological Effects of Ionising Radiation Report VII models of second 
cancer induction and lifetime risks calculated for the five treatment 
classes and intensive imaging regimes. 
Results: The lifetime risk data showed that complex radiotherapy 
techniques did not increase the theoretical risk of second cancer 
incidence for organs distant from the treated breast, or the 
contralateral breast where appropriate constraints were applied. SIB 
treatments were predicted to increase the lifetime risk of second 
cancer incidence in the lungs compared to standard breast 
radiotherapy; this was outweighed by the threefold reduction in 5 yr 
local recurrence risk with adjuvant radiotherapy for a high risk cohort 
for whom these treatments are appropriate. A lower lifetime risk of 
second cancer in the contralateral breast was predicted for the APBI 
method, compared with WBRT. The contribution of imaging dose to 
the total dose from both treatment and imaging did not exceed 22% 
for any measured organ. 
Conclusions: Modern complex radiotherapy techniques used in breast 
cancer were not predicted to increase the theoretical risk of second 
cancer incidence in organs far from the treated breast. Where 
increases in the lifetime risk of induced second cancer were 
predicted, these remained small compared to the large reduction in 
local recurrence risk from receiving RT as a component of treatment. 
